Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

9.3K
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
9.3K
Comparing Mitochondrial, Chloroplast, and Prokaryotic Genomes02:16

Comparing Mitochondrial, Chloroplast, and Prokaryotic Genomes

16.4K
The present-day mitochondrial and chloroplast genomes have retained some of the characteristics of their ancestral prokaryotes and also have acquired new attributes during their evolution within eukaryotic cells. Like prokaryotic genomes, mitochondrial and chloroplast genomes neither bind with histone-like proteins nor show complex packaging into chromosome-like structures, as observed in eukaryotes. Unlike mitotic cell divisions observed in eukaryotic cells, mitochondria and chloroplasts...
16.4K
Export of Mitochondrial and Chloroplast Genes02:19

Export of Mitochondrial and Chloroplast Genes

4.2K
A eukaryotic cell can have up to three different types of genetic systems: nuclear, mitochondrial, and chloroplast. During evolution, organelles have exported many genes to the nucleus; this transfer is still ongoing in some plant species. Approximately 18% of the Arabidopsis thaliana nuclear genome is thought to be derived from the chloroplast’s cyanobacterial ancestor, and around 75% of the yeast genome derived from the mitochondria’s bacterial ancestor. This export has occurred...
4.2K
Tumor Progression02:07

Tumor Progression

7.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.4K
Multiple Allele Traits01:49

Multiple Allele Traits

38.2K
The Concept of Multiple Allelism
38.2K
From DNA to Protein03:06

From DNA to Protein

22.4K
The flow of genetic information in cells from DNA to mRNA to protein is described by the central dogma, which states that genes specify the sequence of mRNAs, which in turn specify the sequence of amino acids making up all proteins. The decoding of one molecule to another is performed by specific proteins and RNAs. Because the information stored in DNA is so central to cellular function, it makes intuitive sense that the cell would make mRNA copies of this information for protein synthesis...
22.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis: a synopsis of MS-STAT2, a multicentre, randomised controlled, double-blind, phase 3 clinical trial.

Health technology assessment (Winchester, England)·2026
Same author

Mavodelpar in patients with primary mitochondrial myopathy: a phase 1 trial.

Scientific reports·2026
Same author

Understanding the Relationship Between Early Elementary Children's ADHD Symptoms and Teachers' Needs Supportive Practices.

Journal of attention disorders·2026
Same author

Quantifying variability of mitochondrial markers in m3243A > G myopathy.

Scientific reports·2025
Same author

Effect of repurposed simvastatin on disability progression in secondary progressive multiple sclerosis (MS-STAT2): a phase 3, randomised, double-blind, placebo-controlled trial.

Lancet (London, England)·2025
Same author

Mitochondrial Donation and Preimplantation Genetic Testing for mtDNA Disease.

The New England journal of medicine·2025

Related Experiment Video

Updated: Feb 6, 2026

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
08:11

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis

Published on: November 14, 2016

11.6K

Cell-free mitochondrial DNA in progressive multiple sclerosis.

Hannah Lowes1, Angela Pyle1, Martin Duddy2

  • 1Institute of Genetic Medicine, International Centre for Life, Central Parkway, Newcastle upon Tyne NE1 3BZ, UK; The Wellcome Centre for Mitochondrial Research, Newcastle University, Medical School, Framlington Place, Newcastle upon Tyne NE2 4HH, UK.

Mitochondrion
|August 12, 2018
PubMed
Summary

Reduced cell-free mitochondrial DNA (ccf-mtDNA) is linked to progressive multiple sclerosis (PMS), a neurodegenerative disease. This finding suggests ccf-mtDNA may be a biomarker for widespread neurodegeneration.

Keywords:
Cell-free mitochondrial DNANeurodegenerationNext-Generation SequencingProgressive Multiple Sclerosis

More Related Videos

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

12.0K
The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.8K

Related Experiment Videos

Last Updated: Feb 6, 2026

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
08:11

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis

Published on: November 14, 2016

11.6K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

12.0K
The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.8K

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Immunology

Background:

  • Cell-free mitochondrial DNA (ccf-mtDNA) is implicated in neurodegeneration in Alzheimer's and Parkinson's diseases.
  • Progressive multiple sclerosis (PMS) exhibits significant neurodegenerative components.

Purpose of the Study:

  • To investigate the role of circulating ccf-mtDNA in end-stage progressive multiple sclerosis (PMS).
  • To compare ccf-mtDNA abundance and integrity in cerebrospinal fluid between PMS patients and controls.
  • To correlate ccf-mtDNA levels with established neurodegeneration and PMS protein markers.

Main Methods:

  • Analysis of ventricular cerebrospinal fluid (CSF) ccf-mtDNA abundance and integrity.
  • Comparison between PMS cases and healthy controls.
  • Correlation of ccf-mtDNA levels with protein markers of neurodegeneration and PMS.

Main Results:

  • Reduced levels of ccf-mtDNA were observed in patients with progressive multiple sclerosis.
  • ccf-mtDNA integrity may also be altered in PMS.
  • ccf-mtDNA levels showed correlations with specific protein markers.

Conclusions:

  • Reduced ccf-mtDNA is a characteristic feature of progressive multiple sclerosis.
  • ccf-mtDNA may serve as a potential biomarker for neurodegeneration in a broader range of diseases.